Loading...
Chemical structure of SAR125844

GC33189

SAR125844

Also known as 1-[6-[[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]-1,3-benzothiazol-2-yl]-3-(2-morpholin-4-ylethyl)urea

SAR125844 is a potent, highly selective, reversible and ATP-competitive MET receptor tyrosine kinase (RTK) inhibitor, with an IC50 of 4·2 nM· Shows inhibition of MET autophosphorylation in cell-based assays

ChemicalCAS1116743-46-4MW550.63FormulaC25H23FN8O2S2
CAS number
1116743-46-4
Molecular weight
550.63
Formula
C25H23FN8O2S2
Solubility
DMSO ： 45 mg/mL (81·72 mM)
InChIKey
ODIUNTQOXRXOIV-UHFFFAOYSA-N
Catalogue number
GC33189
Brand
GLPBIO
Computed properties PubChem CID 25182860 · XLogP 3.4 · TPSA 163 Ų · H-bond donors 2
XLogP
3.4
TPSA
163 Ų
H-bond donors
2
H-bond acceptors
10
Rotatable bonds
7
Heavy atoms
38

SMILES C1COCCN1CCNC(=O)NC2=NC3=C(S2)C=C(C=C3)SC4=NN=C5N4N=C(C=C5)C6=CC=C(C=C6)F

Computed descriptors from PubChem (CID 25182860), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.